Brief: Helix Biopharma Expects Patient Enrollment Will Be Impacted Due To COVID-19
02/04/2020 12:45
April 2 (Reuters) - Helix Biopharma Corp HBP.TO :
* HELIX BIOPHARMA CORP QUARTERLY
* HELIX BIOPHARMA CORP SAYS EXPECTS PATIENT ENROLLMENT WILL
BE
IMPACTED DUE TO COVID-19 CRISIS
Source text for Eikon: ID:nGNX832VXF
Further company coverage: HBP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020